Julie L. Sutcliffe

Title(s)Professor, Hematology and Oncology
SchoolSchool of Medicine
AddressCTSC
CA 95817
vCardDownload vCard

    Collapse Research 
    Collapse Research Activities and Funding
    Peptide-based targeted molecular imaging for early detection in pancreatic cancer
    NIH U01CA217665Aug 15, 2017 - Jul 31, 2022
    Role: Principal Investigator
    First in human study with 18F-avb6-targeting peptide
    NIH R01CA211554Jul 1, 2017 - Jun 30, 2021
    Role: Principal Investigator
    Targeted Molecular Imaging of Plectin-1; Bench to bedside and back again
    NIH R01CA216879Mar 20, 2017 - Feb 28, 2021
    Role: Principal Investigator
    avb6-directed molecular imaging and therapy
    NIH R01CA199725Dec 1, 2015 - Nov 30, 2020
    Role: Principal Investigator
    High throughput design, synthesis and in vivo evaluation of targeted molecular im
    NIH RC4EB012836Sep 30, 2010 - Sep 29, 2013
    Role: Principal Investigator
    An integrated radiopharmaceutical synthesis system
    NIH S10RR024729Apr 1, 2008 - Mar 31, 2010
    Role: Principal Investigator
    Targeting of alpha v beta 6 integrin in oral cancer
    NIH R33CA107792Jun 10, 2004 - Apr 30, 2010
    Role: Principal Investigator
    Targeting of alpha v beta 6 integrin in oral cancer
    NIH R21CA107792Jun 10, 2004 - Apr 30, 2006
    Role: Principal Investigator

    Collapse ORNG Applications 
    Collapse Clinical Trials

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help. to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    Altmetrics Details PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Synthesis and Evaluation of a Monomethyl Auristatin E─Integrin αvβ6 Binding Peptide-Drug Conjugate for Tumor Targeted Drug Delivery. J Med Chem. 2023 07 27; 66(14):9842-9852. Davis RA, Ganguly T, Harris R, Hausner SH, Kovacs L, Sutcliffe JL. PMID: 37417540; PMCID: PMC10388305.
      View in: PubMed   Mentions: 2     Fields:    
    2. Preclinical Evaluation of 68Ga- and 177Lu-Labeled Integrin αvβ6-Targeting Radiotheranostic Peptides. J Nucl Med. 2023 04; 64(4):639-644. Ganguly T, Bauer N, Davis RA, Foster CC, Harris RE, Hausner SH, Roncali E, Tang SY, Sutcliffe JL. PMID: 36207137.
      View in: PubMed   Mentions:    Fields:    Translation:HumansAnimalsCells
    3. A Comparison of Evans Blue and 4-(p-Iodophenyl)butyryl Albumin Binding Moieties on an Integrin αvβ6 Binding Peptide. Pharmaceutics. 2022 Mar 30; 14(4). Davis RA, Hausner SH, Harris R, Sutcliffe JL. PMID: 35456579; PMCID: PMC9025560.
      View in: PubMed   Mentions: 1  
    4. Repurposing an atherosclerosis targeting peptide for tumor imaging. Biomed Pharmacother. 2022 Jan; 145:112469. Kovacs L, Davis RA, Ganguly T, Chammas R, Sutcliffe JL. PMID: 34864315.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansAnimalsCells
    5. Evaluation of Copper-64-Labeled αvβ6-Targeting Peptides: Addition of an Albumin Binding Moiety to Improve Pharmacokinetics. Mol Pharm. 2021 12 06; 18(12):4437-4447. Ganguly T, Bauer N, Davis RA, Hausner SH, Tang SY, Sutcliffe JL. PMID: 34783573.
      View in: PubMed   Mentions: 2     Fields:    Translation:AnimalsCells
    6. Quantitative PET in the 2020s: a roadmap. Phys Med Biol. 2021 03 12; 66(6):06RM01. Meikle SR, Sossi V, Roncali E, Cherry SR, Banati R, Mankoff D, Jones T, James M, Sutcliffe J, Ouyang J, Petibon Y, Ma C, El Fakhri G, Surti S, Karp JS, Badawi RD, Yamaya T, Akamatsu G, Schramm G, Rezaei A, Nuyts J, Fulton R, Kyme A, Lois C, Sari H, Price J, Boellaard R, Jeraj R, Bailey DL, Eslick E, Willowson KP, Dutta J. PMID: 33339012; PMCID: PMC9358699.
      View in: PubMed   Mentions: 16     Fields:    Translation:Humans
    7. Visualizing Cancer. Cancer Cell. 2020 12 14; 38(6):753-756. Krummel M, Hu K, de Vries EGE, Goetz JG, Passaro D, Subramaniam S, Misteli T, Skala M, Bravo-Cordero JJ, Sutcliffe JL. PMID: 33321083.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    8. The Effects of an Albumin Binding Moiety on the Targeting and Pharmacokinetics of an Integrin αvβ6-Selective Peptide Labeled with Aluminum [18F]Fluoride. Mol Imaging Biol. 2020 12; 22(6):1543-1552. Hausner SH, Bauer N, Davis RA, Ganguly T, Tang SYC, Sutcliffe JL. PMID: 32383076; PMCID: PMC7647958.
      View in: PubMed   Mentions: 3     Fields:    Translation:AnimalsCells
    9. Correction to: Evaluation of Two Optical Probes for Imaging the Integrin αvβ6- In Vitro and In Vivo in Tumor-Bearing Mice. Mol Imaging Biol. 2020 10; 22(5):1182-1183. Ganguly T, Tang SY, Bauer N, Sutcliffe JL. PMID: 32253668.
      View in: PubMed   Mentions:    Fields:    
    10. Evaluation of Two Optical Probes for Imaging the Integrin αvβ6- In Vitro and In Vivo in Tumor-Bearing Mice. Mol Imaging Biol. 2020 10; 22(5):1170-1181. Ganguly T, Tang SY, Bauer N, Sutcliffe JL. PMID: 32002763.
      View in: PubMed   Mentions: 4     Fields:    Translation:Animals
    11. αvβ6-Targeted Molecular PET/CT Imaging of the Lungs After SARS-CoV-2 Infection. J Nucl Med. 2020 12; 61(12):1717-1719. Foster CC, Davis RA, Hausner SH, Sutcliffe JL. PMID: 32948681; PMCID: PMC8679627.
      View in: PubMed   Mentions: 14     Fields:    Translation:Humans
    12. Fully automated peptide radiolabeling from [18F]fluoride. RSC Adv. 2019 Mar 12; 9(15):8638-8649. Davis RA, Drake C, Ippisch RC, Moore M, Sutcliffe JL. PMID: 35518701; PMCID: PMC9061836.
      View in: PubMed   Mentions: 4  
    13. Identification, Characterization, and Optimization of Integrin αvβ₆-Targeting Peptides from a One-Bead One-Compound (OBOC) Library: Towards the Development of Positron Emission Tomography (PET) Imaging Agents. Molecules. 2019 Jan 16; 24(2). Tang YSC, Davis RA, Ganguly T, Sutcliffe JL. PMID: 30654483; PMCID: PMC6359284.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansCells
    14. Preclinical Development and First-in-Human Imaging of the Integrin αvβ6 with [18F]αvβ6-Binding Peptide in Metastatic Carcinoma. Clin Cancer Res. 2019 02 15; 25(4):1206-1215. Hausner SH, Bold RJ, Cheuy LY, Chew HK, Daly ME, Davis RA, Foster CC, Kim EJ, Sutcliffe JL. PMID: 30401687; PMCID: PMC6377828.
      View in: PubMed   Mentions: 32     Fields:    Translation:HumansAnimals
    15. ImmunoPET Imaging of αvβ6 Expression Using an Engineered Anti-αvβ6 Cys-diabody Site-Specifically Radiolabeled with Cu-64: Considerations for Optimal Imaging with Antibody Fragments. Mol Imaging Biol. 2018 02; 20(1):103-113. White JB, Hu LY, Boucher DL, Sutcliffe JL. PMID: 28653240.
      View in: PubMed   Mentions: 9     Fields:    Translation:Animals
    16. In Vivo Tracking of Copper-64 Radiolabeled Nanoparticles in Lactuca sativa. Environ Sci Technol. 2017 Nov 07; 51(21):12537-12546. Davis RA, Rippner DA, Hausner SH, Parikh SJ, McElrone AJ, Sutcliffe JL. PMID: 28954194.
      View in: PubMed   Mentions: 5     Fields:    
    17. Glutamine Addiction in Kidney Cancer Suppresses Oxidative Stress and Can Be Exploited for Real-Time Imaging. Cancer Res. 2017 12 01; 77(23):6746-6758. Abu Aboud O, Habib SL, Trott J, Stewart B, Liang S, Chaudhari AJ, Sutcliffe J, Weiss RH. PMID: 29021138; PMCID: PMC5791889.
      View in: PubMed   Mentions: 53     Fields:    Translation:HumansAnimals
    18. WIMIN: Who We Are and What We Do. Mol Imaging Biol. 2017 06; 19(3):328-331. Moore A, Menkens A, Sutcliffe J. PMID: 28255841.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    19. High-Throughput Approaches to the Development of Molecular Imaging Agents. Mol Imaging Biol. 2017 04; 19(2):163-182. Hu LY, Kelly KA, Sutcliffe JL. PMID: 27812924.
      View in: PubMed   Mentions: 6     Fields:    Translation:HumansAnimalsCells
    20. Solid-phase synthesis and fluorine-18 radiolabeling of cycloRGDyK. Org Biomol Chem. 2016 Sep 21; 14(37):8659-8663. Davis RA, Lau K, Hausner SH, Sutcliffe JL. PMID: 27714190; PMCID: PMC5111556.
      View in: PubMed   Mentions: 5     Fields:    
    21. Brain penetrant small molecule (18)F-GnRH receptor (GnRH-R) antagonists: Synthesis and preliminary positron emission tomography imaging in rats. Nucl Med Biol. 2016 08; 43(8):478-89. Olberg DE, Bauer N, Andressen KW, Hjørnevik T, Cumming P, Levy FO, Klaveness J, Haraldsen I, Sutcliffe JL. PMID: 27236283.
      View in: PubMed   Mentions: 4     Fields:    Translation:Animals
    22. Development and characterization of an αvβ6-specific diabody and a disulfide-stabilized αvβ6-specific cys-diabody. Nucl Med Biol. 2015 Dec; 42(12):945-57. White JB, Boucher DL, Zettlitz KA, Wu AM, Sutcliffe JL. PMID: 26341848.
      View in: PubMed   Mentions: 5     Fields:    Translation:HumansCells
    23. Radiosynthesis of high affinity fluorine-18 labeled GnRH peptide analogues: in vitro studies and in vivo assessment of brain uptake in rats. MedChemComm. 2015 Apr 10; 6(4):708-714. Olberg OD, Hausner HS, Bauer BN, Klaveness KJ, Indrevoll IB, Andressen AK, Dahl DM, Levy LF, Sutcliffe SJ, Haraldsen HI. .
      View in: Publisher Site   Mentions:
    24. The Effect of Bi-Terminal PEGylation of an Integrin αvβ₆-Targeted ¹⁸F Peptide on Pharmacokinetics and Tumor Uptake. J Nucl Med. 2015 May; 56(5):784-90. Hausner SH, Bauer N, Hu LY, Knight LM, Sutcliffe JL. PMID: 25814519; PMCID: PMC4559355.
      View in: PubMed   Mentions: 24     Fields:    Translation:HumansAnimalsCells
    25. Synthesis of [64Cu]DOTA-ADIBON3-Ala-PEG28-A20FMDV2 via copper-free click chemistry for PET imaging of integrin avß6. Journal of Radioanalytical and Nuclear Chemistry. 2014 Nov 1; 302(2):765-771. Satpati SD, Bauer BN, Hausner HS, Sutcliffe SJ. .
      View in: Publisher Site   Mentions:
    26. Implantable biomaterial based on click chemistry for targeting small molecules. Acta Biomater. 2014 Dec; 10(12):5099-5105. Mejía Oneto JM, Gupta M, Leach JK, Lee M, Sutcliffe JL. PMID: 25162537.
      View in: PubMed   Mentions: 9     Fields:    Translation:Animals
    27. Characterization and evaluation of (64)Cu-labeled A20FMDV2 conjugates for imaging the integrin αvβ 6. Mol Imaging Biol. 2014 Aug; 16(4):567-77. Hu LY, Bauer N, Knight LM, Li Z, Liu S, Anderson CJ, Conti PS, Sutcliffe JL. PMID: 24448825; PMCID: PMC4277820.
      View in: PubMed   Mentions: 14     Fields:    Translation:Animals
    28. Cerenkov luminescence imaging of αv β6 integrin expressing tumors using (90) Y-labeled peptides. J Labelled Comp Radiopharm. 2014 Jul; 57(9):558-65. Satpati D, Hausner SH, Bauer N, Sutcliffe JL. PMID: 25042833.
      View in: PubMed   Mentions: 4     Fields:    Translation:AnimalsCells
    29. Photodegradable hydrogels for capture, detection, and release of live cells. Angew Chem Int Ed Engl. 2014 Jul 28; 53(31):8221-4. Shin DS, You J, Rahimian A, Vu T, Siltanen C, Ehsanipour A, Stybayeva G, Sutcliffe J, Revzin A. PMID: 24931301; PMCID: PMC4380505.
      View in: PubMed   Mentions: 21     Fields:    Translation:HumansCells
    30. Synthesis and in vitro evaluation of small-molecule [18F] labeled gonadotropin-releasing hormone (GnRH) receptor antagonists as potential PET imaging agents for GnRH receptor expression. Bioorg Med Chem Lett. 2014 Apr 01; 24(7):1846-50. Olberg DE, Andressen KW, Levy FO, Klaveness J, Haraldsen I, Sutcliffe JL. PMID: 24613701.
      View in: PubMed   Mentions: 5     Fields:    Translation:HumansAnimalsCells
    31. In vivo tracking of Th1 cells by PET reveals quantitative and temporal distribution and specific homing in lymphatic tissue. J Nucl Med. 2014 Feb; 55(2):301-7. Griessinger CM, Kehlbach R, Bukala D, Wiehr S, Bantleon R, Cay F, Schmid A, Braumüller H, Fehrenbacher B, Schaller M, Eichner M, Sutcliffe JL, Ehrlichmann W, Eibl O, Reischl G, Cherry SR, Röcken M, Pichler BJ, Kneilling M. PMID: 24434289.
      View in: PubMed   Mentions: 34     Fields:    Translation:AnimalsCells
    32. Rapid 18 F-radiolabeling of peptides from [ 18 F]fluoride using a single microfluidics device. RSC Advances. 2014 Jan 1; 4(90):49529-49534. Cumming CR, Olberg OD, Sutcliffe SJ. .
      View in: Publisher Site   Mentions:
    33. In vitro and in vivo evaluation of the effects of aluminum [¹⁸F]fluoride radiolabeling on an integrin αvβ₆-specific peptide. Nucl Med Biol. 2014 Jan; 41(1):43-50. Hausner SH, Bauer N, Sutcliffe JL. PMID: 24267053.
      View in: PubMed   Mentions: 21     Fields:    Translation:AnimalsCells
    34. Micropatterned photodegradable hydrogels for the sorting of microbeads and cells. Angew Chem Int Ed Engl. 2013 Aug 26; 52(35):9224-8. Siltanen C, Shin DS, Sutcliffe J, Revzin A. PMID: 23868693; PMCID: PMC4370904.
      View in: PubMed   Mentions: 10     Fields:    Translation:AnimalsCells
    35. Evaluation of an integrin αvβ6-specific peptide labeled with [18F]fluorine by copper-free, strain-promoted click chemistry. Nucl Med Biol. 2013 Feb; 40(2):233-9. Hausner SH, Carpenter RD, Bauer N, Sutcliffe JL. PMID: 23265667.
      View in: PubMed   Mentions: 29     Fields:    Translation:AnimalsCells
    36. Optimization of the solid-phase synthesis of [18F] radiolabeled peptides for positron emission tomography. Appl Radiat Isot. 2012 Dec; 70(12):2720-9. White JB, Hausner SH, Carpenter RD, Sutcliffe JL. PMID: 23041391.
      View in: PubMed   Mentions: 5     Fields:    
    37. Functional fluorescently labeled bithiazole ΔF508-CFTR corrector imaged in whole body slices in mice. Bioconjug Chem. 2011 Dec 21; 22(12):2593-9. Davison HR, Taylor S, Drake C, Phuan PW, Derichs N, Yao C, Jones EF, Sutcliffe J, Verkman AS, Kurth MJ. PMID: 22034937; PMCID: PMC3245868.
      View in: PubMed   Mentions: 6     Fields:    Translation:Animals
    38. Copper-Free Click for PET: Rapid 1,3-Dipolar Cycloadditions with a Fluorine-18 Cyclooctyne. ACS Med Chem Lett. 2011 Dec 08; 2(12):885-9. Carpenter RD, Hausner SH, Sutcliffe JL. PMID: 24900276; PMCID: PMC4018166.
      View in: PubMed   Mentions: 21  
    39. Photolabile micropatterned surfaces for cell capture and release. Chem Commun (Camb). 2011 Nov 21; 47(43):11942-4. Shin DS, Seo JH, Sutcliffe JL, Revzin A. PMID: 21970983.
      View in: PubMed   Mentions: 8     Fields:    Translation:HumansCells
    40. Nanomedicine explored at molecular imaging summit. Mol Imaging. 2011 Feb; 10(1):1. Sutcliffe JL. PMID: 21303610.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    41. High-throughput in vivo screening of targeted molecular imaging agents. Proc Natl Acad Sci U S A. 2009 Oct 20; 106(42):17904-9. Gagnon MK, Hausner SH, Marik J, Abbey CK, Marshall JF, Sutcliffe JL. PMID: 19815497; PMCID: PMC2764889.
      View in: PubMed   Mentions: 33     Fields:    Translation:AnimalsCells
    42. Preclinical evaluation of carcinoembryonic cell adhesion molecule (CEACAM) 6 as potential therapy target for pancreatic adenocarcinoma. J Pathol. 2009 Jul; 218(3):380-90. Strickland LA, Ross J, Williams S, Ross S, Romero M, Spencer S, Erickson R, Sutcliffe J, Verbeke C, Polakis P, van Bruggen N, Koeppen H. PMID: 19334050.
      View in: PubMed   Mentions: 28     Fields:    Translation:HumansAnimalsCells
    43. Targeted in vivo imaging of integrin alphavbeta6 with an improved radiotracer and its relevance in a pancreatic tumor model. Cancer Res. 2009 Jul 15; 69(14):5843-50. Hausner SH, Abbey CK, Bold RJ, Gagnon MK, Marik J, Marshall JF, Stanecki CE, Sutcliffe JL. PMID: 19549907; PMCID: PMC2711989.
      View in: PubMed   Mentions: 49     Fields:    Translation:HumansAnimalsCells
    44. 111In-LLP2A-DOTA Polyethylene Glycol-Targeting {alpha}4{beta}1 Integrin: Comparative Pharmacokinetics for Imaging and Therapy of Lymphoid Malignancies. J Nucl Med. 2009 Apr; 50(4):625-34. Denardo SJ, Liu R, Albrecht H, Natarajan A, Sutcliffe JL, Anderson C, Peng L, Ferdani R, Cherry SR, Lam KS. PMID: 19289419.
      View in: PubMed   Mentions: 21     Fields:    Translation:HumansAnimalsCells
    45. Evaluation of [64Cu]Cu-DOTA and [64Cu]Cu-CB-TE2A chelates for targeted positron emission tomography with an alphavbeta6-specific peptide. Mol Imaging. 2009 Mar-Apr; 8(2):111-21. Hausner SH, Kukis DL, Gagnon MK, Stanecki CE, Ferdani R, Marshall JF, Anderson CJ, Sutcliffe JL. PMID: 19397856; PMCID: PMC4287215.
      View in: PubMed   Mentions: 23     Fields:    Translation:AnimalsCells
    46. Arginine deiminase as a novel therapy for prostate cancer induces autophagy and caspase-independent apoptosis. Cancer Res. 2009 Jan 15; 69(2):700-8. Kim RH, Coates JM, Bowles TL, McNerney GP, Sutcliffe J, Jung JU, Gandour-Edwards R, Chuang FY, Bold RJ, Kung HJ. PMID: 19147587; PMCID: PMC2629384.
      View in: PubMed   Mentions: 142     Fields:    Translation:HumansAnimalsCells
    47. Imaging and pharmacokinetics of (64)Cu-DOTA-HB22.7 administered by intravenous, intraperitoneal, or subcutaneous injection to mice bearing non-Hodgkin's lymphoma xenografts. Mol Imaging Biol. 2009 Mar-Apr; 11(2):79-87. Martin SM, O'Donnell RT, Kukis DL, Abbey CK, McKnight H, Sutcliffe JL, Tuscano JM. PMID: 18949521.
      View in: PubMed   Mentions: 6     Fields:    Translation:Animals
    48. In vivo positron emission tomography (PET) imaging with an alphavbeta6 specific peptide radiolabeled using 18F-"click" chemistry: evaluation and comparison with the corresponding 4-[18F]fluorobenzoyl- and 2-[18F]fluoropropionyl-peptides. J Med Chem. 2008 Oct 09; 51(19):5901-4. Hausner SH, Marik J, Gagnon MK, Sutcliffe JL. PMID: 18785727; PMCID: PMC2630402.
      View in: PubMed   Mentions: 31     Fields:    Translation:HumansAnimalsCells
    49. Preoperative evaluation of pancreatic adenocarcinoma. J Hepatobiliary Pancreat Surg. 2008; 15(4):429-35. Parsons CM, Sutcliffe JL, Bold RJ. PMID: 18670846.
      View in: PubMed   Mentions: 20     Fields:    Translation:Humans
    50. Dynamic imaging of arginine-rich heart-targeted vehicles in a mouse model. Biomaterials. 2008 Apr; 29(12):1976-88. Zhang H, Kusunose J, Kheirolomoom A, Seo JW, Qi J, Watson KD, Lindfors HA, Ruoslahti E, Sutcliffe JL, Ferrara KW. PMID: 18255141; PMCID: PMC2475513.
      View in: PubMed   Mentions: 21     Fields:    Translation:Animals
    51. Radiolabeling rhesus monkey CD34+ hematopoietic and mesenchymal stem cells with 64Cu-pyruvaldehyde-bis(N4-methylthiosemicarbazone) for microPET imaging. Mol Imaging. 2008 Jan-Feb; 7(1):1-11. Huang J, Lee CC, Sutcliffe JL, Cherry SR, Tarantal AF. PMID: 18384718.
      View in: PubMed   Mentions: 30     Fields:    Translation:AnimalsCells
    52. From combinatorial chemistry to cancer-targeting peptides. Mol Pharm. 2007 Sep-Oct; 4(5):631-51. Aina OH, Liu R, Sutcliffe JL, Marik J, Pan CX, Lam KS. PMID: 17880166.
      View in: PubMed   Mentions: 89     Fields:    Translation:HumansAnimals
    53. Use of a peptide derived from foot-and-mouth disease virus for the noninvasive imaging of human cancer: generation and evaluation of 4-[18F]fluorobenzoyl A20FMDV2 for in vivo imaging of integrin alphavbeta6 expression with positron emission tomography. Cancer Res. 2007 Aug 15; 67(16):7833-40. Hausner SH, DiCara D, Marik J, Marshall JF, Sutcliffe JL. PMID: 17699789.
      View in: PubMed   Mentions: 61     Fields:    Translation:HumansAnimalsCells
    54. Long-circulating liposomes radiolabeled with [18F]fluorodipalmitin ([18F]FDP). Nucl Med Biol. 2007 Feb; 34(2):165-71. Marik J, Tartis MS, Zhang H, Fung JY, Kheirolomoom A, Sutcliffe JL, Ferrara KW. PMID: 17307124; PMCID: PMC1849971.
      View in: PubMed   Mentions: 42     Fields:    Translation:Animals
    55. Structure-function analysis of Arg-Gly-Asp helix motifs in alpha v beta 6 integrin ligands. J Biol Chem. 2007 Mar 30; 282(13):9657-9665. DiCara D, Rapisarda C, Sutcliffe JL, Violette SM, Weinreb PH, Hart IR, Howard MJ, Marshall JF. PMID: 17244604.
      View in: PubMed   Mentions: 41     Fields:    Translation:HumansAnimalsCells
    56. Click for PET: rapid preparation of [18F]fluoropeptides using CuI catalyzed 1,3-dipolar cycloaddition. Tetrahedron Letters. 2006 Sep 1; 47(37):6681-6684. Marik MJ, Sutcliffe SJ. .
      View in: Publisher Site   Mentions:
    57. Fully automated preparation of n.c.a. 4-[18F]fluorobenzoic acid and N-succinimidyl 4-[18F]fluorobenzoate using a Siemens/CTI chemistry process control unit (CPCU). Appl Radiat Isot. 2007 Feb; 65(2):199-203. Marik J, Sutcliffe JL. PMID: 16935516.
      View in: PubMed   Mentions: 20     Fields:    
    58. Solid-phase synthesis of 2-[18F]fluoropropionyl peptides. Bioconjug Chem. 2006 Jul-Aug; 17(4):1017-21. Marik J, Hausner SH, Fix LA, Gagnon MK, Sutcliffe JL. PMID: 16848410.
      View in: PubMed   Mentions: 9     Fields:    Translation:Cells
    59. Differential changes in brain glucose metabolism during hypoglycaemia accompany loss of hypoglycaemia awareness in men with type 1 diabetes mellitus. An [11C]-3-O-methyl-D-glucose PET study. Diabetologia. 2005 Oct; 48(10):2080-9. Bingham EM, Dunn JT, Smith D, Sutcliffe-Goulden J, Reed LJ, Marsden PK, Amiel SA. PMID: 16143864.
      View in: PubMed   Mentions: 28     Fields:    Translation:Humans
    60. Analysis of the regional uptake of radiolabeled deoxyglucose analogs in human tumor xenografts. J Nucl Med. 2004 Jan; 45(1):101-7. Dearling JL, Flynn AA, Sutcliffe-Goulden J, Petrie IA, Boden R, Green AJ, Boxer GM, Begent RH, Pedley RB. PMID: 14734681.
      View in: PubMed   Mentions: 18     Fields:    Translation:HumansAnimalsCells
    61. Rapid solid phase synthesis and biodistribution of 18F-labelled linear peptides. Eur J Nucl Med Mol Imaging. 2002 Jun; 29(6):754-9. Sutcliffe-Goulden JL, O'Doherty MJ, Marsden PK, Hart IR, Marshall JF, Bansal SS. PMID: 12029548.
      View in: PubMed   Mentions: 20     Fields:    Translation:AnimalsCells
    62. Solid phase synthesis of [18F]labelled peptides for positron emission tomography. Bioorg Med Chem Lett. 2000 Jul 17; 10(14):1501-3. Sutcliffe-Goulden JL, O'Doherty MJ, Bansal SS. PMID: 10915036.
      View in: PubMed   Mentions: 6     Fields:    Translation:Cells
    63. Principles and technology of PET scanning. Nucl Med Commun. 2000 Mar; 21(3):221-4. Marsden P, Sutcliffe-Goulden J. PMID: 10823321.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansAnimals
    64. Optimization of noise-equivalent count rates in 3D PET. Phys Med Biol. 1996 Sep; 41(9):1755-76. Badawi RD, Marsden PK, Cronin BF, Sutcliffe JL, Maisey MN. PMID: 8884911.
      View in: PubMed   Mentions: 12     Fields:    Translation:Humans
    With one click, see people who:

    Mentor

    Offer Student Projects

    Run Clinical Trials

    See more options in the Advanced Search tab

    Julie's Networks
    Concepts (275)
    Derived automatically from this person's publications.
    Explore
    _
    Co-Authors (28)
    People in Profiles who have published with this person.
    Explore
    _
    Similar People (60)
    People who share similar concepts with this person.
    Explore
    _
    Same Department
    Search Department
    _

    UC Davis Profiles is managed by the UCSF Clinical and Translational Science Institute (CTSI), part of the Clinical and Translational Science Award program funded by the National Center for Advancing Translational Sciences (Grant Number UL1 TR000004) at the National Institutes of Health (NIH).
    This site is running Profiles RNS version UCSF-v3.1.0-3-g1ef1264b on PROFILES-PWEB04. We use cookies to operate our website. We also use cookies to analyze our site’s performance and improve your experience on our site. For more information about how we use cookies, please see our Website Terms of Use.

    Copyright © The Regents of the University of California